Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3/c-Myc signaling pathway in human

Rende Ning1, Guang Chen2, Run Fang2

  • 1Department of Orthopaedics, The Third Affiliated Hospital of Anhui Medical University, 390 Huaihe Road, Hefei, 230031, China. nrd192@qq.com.

Biological Research
|December 19, 2021
PubMed
Abstract

Insights

Diosmetin, a citrus bioflavonoid, effectively inhibits osteosarcoma cell growth and promotes apoptosis. It achieves this by suppressing the STAT3/c-Myc signaling pathway, offering potential as a new cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Diosmetin is a naturally occurring bioflavonoid found in citrus fruits.
  • Its potential antitumor effects, particularly in osteosarcoma, were previously unexplored.

Purpose of the Study:

  • To investigate the antitumor properties of diosmetin in human osteosarcoma cells.
  • To elucidate the underlying molecular mechanisms, including its effect on cell proliferation, apoptosis, and the STAT3/c-Myc pathway.

Main Methods:

  • Cell proliferation and apoptosis assays (colony formation, cell cycle, apoptosis analysis).
  • Western blot and immunoprecipitation to analyze protein expression and pathway activation.
  • Experiments conducted on Saos-2 and U2SO human osteosarcoma cell lines.

Main Results:

  • Diosmetin significantly inhibited osteosarcoma cell proliferation and induced apoptosis.
  • It caused cell cycle arrest at the G2/M phase.
  • Diosmetin downregulated anti-apoptotic proteins (Bcl-xL) and upregulated pro-apoptotic proteins (cleaved Caspase-3, cleaved-PARP, Bax).
  • It inhibited STAT3 phosphorylation, reduced c-Myc expression, and disrupted STAT3 molecular interactions.

Conclusions:

  • Diosmetin exhibits significant anti-osteosarcoma effects.
  • These effects are mediated by the suppression of cell proliferation and induction of apoptosis.
  • Inhibition of the STAT3/c-Myc signaling pathway is a key mechanism.
  • Diosmetin shows promise as a potential chemotherapeutic agent for osteosarcoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.8K